310 related articles for article (PubMed ID: 9625195)
1. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns.
Weiner M; Powe NR; Weller WE; Shaffer TJ; Anderson GF
J Am Geriatr Soc; 1998 Jun; 46(6):762-70. PubMed ID: 9625195
[TBL] [Abstract][Full Text] [Related]
2. Capitation, managed care, and chronic obstructive pulmonary disease.
Grasso ME; Weller WE; Shaffer TJ; Diette GB; Anderson GF
Am J Respir Crit Care Med; 1998 Jul; 158(1):133-8. PubMed ID: 9655719
[TBL] [Abstract][Full Text] [Related]
3. How well does a single question about health predict the financial health of Medicare managed care plans?
Bierman AS; Bubolz TA; Fisher ES; Wasson JH
Eff Clin Pract; 1999; 2(2):56-62. PubMed ID: 10538477
[TBL] [Abstract][Full Text] [Related]
4. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.
Krop JS; Powe NR; Weller WE; Shaffer TJ; Saudek CD; Anderson GF
Diabetes Care; 1998 May; 21(5):747-52. PubMed ID: 9589235
[TBL] [Abstract][Full Text] [Related]
5. Capitation for cardiologists: accepting risk for coronary artery disease under managed care.
McNamara RL; Powe NR; Shaffer T; Thiemann D; Weller W; Anderson G
Am J Cardiol; 1998 Nov; 82(10):1178-82. PubMed ID: 9832090
[TBL] [Abstract][Full Text] [Related]
6. Changes in Utilization and Expenditures for Medicare Beneficiaries in Patient-centered Medical Homes: Findings From the Multi-Payer Advanced Primary Care Practice Demonstration.
Nichols DE; Haber SG; Romaire MA; Wensky SG;
Med Care; 2018 Sep; 56(9):775-783. PubMed ID: 30052548
[TBL] [Abstract][Full Text] [Related]
7. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records.
Newcomer R; Clay T; Luxenberg JS; Miller RH
J Am Geriatr Soc; 1999 Feb; 47(2):215-9. PubMed ID: 9988293
[TBL] [Abstract][Full Text] [Related]
8. Risk adjustment for Medicare beneficiaries with Alzheimer's disease and related dementias.
Lin PJ; Maciejewski ML; Paul JE; Biddle AK
Am J Manag Care; 2010 Mar; 16(3):191-8. PubMed ID: 20225914
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
[TBL] [Abstract][Full Text] [Related]
10. The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.
Buntin MB; Garber AM; McClellan M; Newhouse JP
Health Serv Res; 2004 Feb; 39(1):111-30. PubMed ID: 14965080
[TBL] [Abstract][Full Text] [Related]
11. Cost of Alzheimer's disease and related dementia in managed-medicare.
Gutterman EM; Markowitz JS; Lewis B; Fillit H
J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247
[TBL] [Abstract][Full Text] [Related]
12. High-Need Phenotypes in Medicare Beneficiaries: Drivers of Variation in Utilization and Outcomes.
Keeney T; Belanger E; Jones RN; Joyce NR; Meyers DJ; Mor V
J Am Geriatr Soc; 2020 Jan; 68(1):70-77. PubMed ID: 31454082
[TBL] [Abstract][Full Text] [Related]
13. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use.
Bynum JP; Rabins PV; Weller W; Niefeld M; Anderson GF; Wu AW
J Am Geriatr Soc; 2004 Feb; 52(2):187-94. PubMed ID: 14728626
[TBL] [Abstract][Full Text] [Related]
14. Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care.
Fowler FJ; Gallagher PM; Anthony DL; Larsen K; Skinner JS
JAMA; 2008 May; 299(20):2406-12. PubMed ID: 18505950
[TBL] [Abstract][Full Text] [Related]
15. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders.
Lin PJ; Fillit HM; Cohen JT; Neumann PJ
Alzheimers Dement; 2013 Jan; 9(1):30-8. PubMed ID: 23305822
[TBL] [Abstract][Full Text] [Related]
16. Differences in Medicare Utilization and Expenditures in the Last Six Months of Life among Patients with and without Alzheimer's Disease and Related Disorders.
Crouch E; Probst JC; Bennett K; Eberth JM
J Palliat Med; 2019 Feb; 22(2):126-131. PubMed ID: 30328762
[TBL] [Abstract][Full Text] [Related]
17. Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
Krumholz HM; Nuti SV; Downing NS; Normand SL; Wang Y
JAMA; 2015 Jul; 314(4):355-65. PubMed ID: 26219053
[TBL] [Abstract][Full Text] [Related]
18. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias.
Lin PJ; Biddle AK; Ganguly R; Kaufer DI; Maciejewski ML
Med Care; 2009 Nov; 47(11):1174-9. PubMed ID: 19786913
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.
Fahlman C; Lynn J; Doberman D; Gabel J; Finch M
J Palliat Med; 2006 Aug; 9(4):884-93. PubMed ID: 16910803
[TBL] [Abstract][Full Text] [Related]
20. Association of managed care market share and health expenditures for fee-for-service Medicare patients.
Baker LC
JAMA; 1999 Feb; 281(5):432-7. PubMed ID: 9952203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
